Zentalis Pharmaceuticals to Host a Key Opinion Leader Virtual Meeting to Discuss its Investigational WEE1 Inhibitor ZN-c3 and its Potential as a Best-in-Class Treatment for Advanced Solid Tumors

    NEXT STORY
    Ascendis Pharma A/S Announces Participation at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
    PREV STORY
    MediciNova Announces that BioComo’s Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Clinical Cancer Research Highlights Potent Antitumor Activity of Repotrectinib in Treatment-Naïve and Solvent-Front Mutation Ros1-Positive Non-Small Cell Lung Cancer

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Biocartis to host webcast for announcement 2017 financial results on 1 March 2018

      PRESS RELEASE: REGULATED INFORMATION 22 February 2018, 07:00 CET BioCARTIS to Host Webcast FOR ...

    author_avatar
    NASDAQ Market News

    Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update

    author_avatar
    NASDAQ Market News